Investors
ANNOUNCEMENT
bonyf is listed on Euronext Paris
since 17th of March 2022
Documentation
Annual Financial Report
Press Releases
General Information
Why does bonyf go public?
- To increase visibility, credibility and awareness. bonyf will be the first oral/dental care company listed on Euronext Paris;
- Enter into licensing agreements with larger companies;
- Invest in new product development and further clinical studies;
- Create brand and product awareness.
How do I subscribe to buy bonyf shares?
You must have an account with a bank, stockbroker, online broker etc. Choose between either a securities account or a stock savings plan. When you subscribe to bonyf shares internationally, your bank will need the Mnemonic Code MLBON and the ISIN (International Securities Identification Number) Code BE6333353298. See technical information below.
Technical Information
Registration procedure: | Technical admission |
Number of shares admitted: | 588,600 |
Share price: | € 12 |
Company value at registration: | € 7,063,200 |
ISIN Code: | BE6333353298 |
Mnemonic Code: | MLBON |
The operation is being carried out in the context of a listing procedure on the Euronext Access market, by way of technical admission of bonyf shares. It does not require the approval of the French Financial Market Authorities (Autorité des Marchés Financiers) in accordance with the guidelines of the Euronext Access market.
Shareholder Information
BE6333353298
MLBON
Euronext Access Paris
20103015 – Pharmaceutical
Breakdown of Share Capital Pre-listing on Euronext Access
Shareholders | No. of Shares | % of Share Capital | Voting Rights | % of Voting Rights |
---|---|---|---|---|
Jean-Pierre Bogaert | 295,474 | 50.20% | 295,474 | 50.20% |
Ginette Buyle | 293,125 | 49.80% | 293,125 | 49.80% |
Other | 1 | < 0.01% | 1 | < 0.01% |
Total | 588,600 | 100% | 588,600 | 100% |
For any questions about Investor Relations
please contact our team
Vait Cerkezi
Chief Operating Officer
Dr Bart de Wever
Chief Scientific Officer